Epigenetic and transcriptional consequences of Intellectual Disability-associated mutations in the histone lysine demethylase KDM5.

组蛋白赖氨酸去甲基化酶 KDM5 中与智力障碍相关的突变的表观遗传和转录后果。

基本信息

  • 批准号:
    10625335
  • 负责人:
  • 金额:
    $ 4.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-16 至 2026-05-15
  • 项目状态:
    未结题

项目摘要

ABSTRACT Intellectual disabilities (ID) are a group of neurodevelopmental disorders characterized by difficulties in memory, cognition, and adaptive function by the age of 18. Whole exome sequencing from patients with ID reveals mutations in the genes encoding KDM5A, B, and C. One to three percent of X-linked ID (X-LID) is attributed to the highly neuronally expressed paralog KDM5C. KDM5 proteins are best known for their enzymatic demethylation of H3 that is tri-methylated on lysine 4 (H3K4me3), a chromatin modification associated with transcriptionally active promoters. Though Kdm5c knockout mice show cognitive phenotypes, no clinically relevant pathways have been identified and the mechanism by which KDM5 regulates transcription is still unclear. Drosophila possess a single, well conserved ortholog of KDM5 in which we can model patient- associated ID mutations to understand their effects on neuronal development. A previous study from our lab modeling ID mutations in Drosophila reveals a reduction in expression of ribosomal protein genes (RPG), total protein translation, and defects in both short and long-term memory. De novo translation is necessary for memory formation and is found to be altered in several ID disorders. Importantly, restoring translational defects are an emerging and potentially therapeutic means to improve the cognitive function of individuals with ID. Hindering the development of any therapies is a lack of understanding of how KDM5 functions molecularly to regulate the expression of RP and other genes, the extent to which this requires its canonical histone demethylase activity, and how KDM5 function is altered by ID-associated mutations. Here, we specifically address these key issues by systematically decoding the role of KDM5 in RPG expression by assessing promoter H3K4me3 levels, the KDM5 interactome, and how these are altered by ID mutations.
摘要 智力障碍(ID)是一组以记忆障碍为特征的神经发育障碍, 18岁前的认知和适应功能。ID患者的整个外显子组序列显示 编码KDM5A、B和C的基因突变1%到3%的X连锁ID(X-LID)被归因于 高神经元表达的Paralog KDM5C。KDM5蛋白最为人所知的是它们的酶 赖氨酸4(H3K4me3)上三甲基化的H3去甲基化,一种与 转录活性启动子。虽然Kdm5c基因敲除小鼠表现出认知表型,但在临床上没有 相关的途径已经确定,KDM5调节转录的机制仍然是 不清楚。果蝇拥有一个保守的KDM5同源基因,我们可以在其中模拟患者- 相关的ID突变,以了解它们对神经元发育的影响。我们实验室以前的一项研究 在果蝇中模拟ID突变显示核糖体蛋白基因(RPG)的表达减少,总 蛋白质翻译,以及短期和长期记忆的缺陷。从头翻译对于记忆来说是必要的 形成,并被发现在几个ID障碍中改变。重要的是,修复翻译缺陷是一种 新兴和潜在的治疗手段,以改善ID障碍患者的认知功能 任何疗法的发展都是缺乏对KDM5如何在分子上调节 RP和其他基因的表达,这需要其标准组蛋白去甲基酶活性的程度, 以及ID相关突变如何改变KDM5的功能。在这里,我们专门解决这些关键问题 通过系统地解码KDM5在RPG表达中的作用,通过评估启动子H3K4me3的水平, KDM5互动组,以及ID突变是如何改变这些的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matanel Yheskel其他文献

Matanel Yheskel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matanel Yheskel', 18)}}的其他基金

Epigenetic and transcriptional consequences of Intellectual Disability-associated mutations in the histone lysine demethylase KDM5.
组蛋白赖氨酸去甲基化酶 KDM5 中与智力障碍相关的突变的表观遗传和转录后果。
  • 批准号:
    10460743
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了